Arcutis Biotherapeutics, Inc.（ARQT）内部人交易：高管与董事近期交易
过去 18 个月，共有 16 位内部人为 Arcutis Biotherapeutics, Inc.（ARQT）报告了 179 笔 Form 4 交易（最近一笔 2026-09-18）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-18 | Matsuda Masaru | Reporting Person's title: EVP, Chief Legal Officer | 卖出 | 3,674 | $91,853 |
| 2026-09-17 | Welgus Howard G. | 董事 | 买入 | 822 | $5,361 |
| 2026-09-17 | Welgus Howard G. | 董事 | 买入 | 1,019 | $7,653 |
| 2026-09-17 | Welgus Howard G. | 董事 | 买入 | 2,255 | $19,461 |
| 2026-09-17 | Welgus Howard G. | 董事 | 卖出 | 4,730 | $114,371 |
| 2026-09-10 | Matsuda Masaru | Reporting Person's title: EVP, Chief Legal Officer | 卖出 | 9,989 | $249,986 |
| 2026-08-28 | Curran Terrie | 董事 | 买入 | 11,148 | $83,721 |
| 2026-08-28 | Curran Terrie | 董事 | 卖出 | 11,148 | $279,028 |
| 2026-08-28 | Curran Terrie | 董事 | 买入 | 27,052 | $233,459 |
| 2026-08-28 | Curran Terrie | 董事 | 卖出 | 27,052 | $677,095 |
| 2026-08-24 | Curran Terrie | 董事 | 买入 | 1,072 | $8,051 |
| 2026-08-24 | Curran Terrie | 董事 | 卖出 | 1,072 | $27,912 |
| 2026-08-21 | Burnett Patrick | Reporting Person's title: EVP, Chief Medical Officer | 卖出 | 1,697 | $45,819 |
| 2026-08-19 | Welgus Howard G. | 董事 | 买入 | 822 | $5,361 |
| 2026-08-19 | Welgus Howard G. | 董事 | 买入 | 1,019 | $7,653 |
| 2026-08-19 | Welgus Howard G. | 董事 | 买入 | 2,255 | $19,461 |
| 2026-08-19 | Welgus Howard G. | 董事 | 卖出 | 4,730 | $123,835 |
| 2026-08-13 | Burnett Patrick | Reporting Person's title: EVP, Chief Medical Officer | 买入 | 8,300 | $30,212 |
| 2026-08-13 | Burnett Patrick | Reporting Person's title: EVP, Chief Medical Officer | 卖出 | 8,300 | $220,129 |
| 2026-08-13 | Burnett Patrick | Reporting Person's title: EVP, Chief Medical Officer | 买入 | 6,700 | $24,388 |
| 2026-08-13 | Burnett Patrick | Reporting Person's title: EVP, Chief Medical Officer | 卖出 | 6,700 | $174,767 |
| 2026-08-05 | Burnett Patrick | Reporting Person's title: EVP, Chief Medical Officer | 卖出 | 955 | $24,942 |
| 2026-08-05 | Matsuda Masaru | Reporting Person's title: EVP, Chief Legal Officer | 卖出 | 1,230 | $32,124 |
| 2026-08-05 | Watanabe Todd | Reporting Person's title: President and Chief Executive Officer | 卖出 | 4,375 | $114,261 |
| 2026-07-17 | Peetz Christopher | 董事 | 买入 | 4,315 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-18